EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Radionuclidic Impurity Pathways in Cyclotron Production: Insights from 18F and Emerging Theranostic Radionuclides

Teresa Jakubowska iD, Magdalena Długosz-Lisiecka iD, Jarosław Jankowski iD, Michał Biegała iD

Molecules · 05.11.2026 · 31 (21) · 3987

DOI: 10.3390/molecules31213987 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 05.11.2026. Verfasst von Teresa Jakubowska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging Technology, Medical University of Lodz, ul. Lindleya 6, 90-131 Łódź, Poland. Die Arbeit nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1) Cyclotron production of medical radionuclides can generate unintended radionuclidic impurities, influencing product quality, radiation safety, and radioactive waste management. This review aims to establish a general mechanistic framework for the formation, transfer, and control of such impurities. (2) We identified published data on theranostic radionuclides, liquid- and solid-target production, 18F-associated impurities, and activation products through a Scopus search and reference screening. A total of 147 publications were qualitatively synthesized. (3) Production of 18F from H218O served as a reference model for tracing impurity pathways from irradiation through transfer, purification, radiosynthesis, and waste management. Three principal sources can be distinguished: competing nuclear reactions involving the target isotope and residual isotopes; reactions involving other target-matrix constituents; and activation of target windows, bodies, and auxiliary materials. Impurity fate depends on release from the formation site, transfer into the processing stream, and retention or removal during purification and radiosynthesis. (4) The 18F model demonstrates that all of these stages should be considered when designing and validating new cyclotron-production routes. Co-produced isotopes of the product element require predominantly upstream control, whereas chemically distinct radionuclides can often be separated but are redistributed within the manufacturing system.

Schlagwörter

Stichwörter der Autor:innen

activation productscyclotron productionfluorine-18radiation protectionradionuclidic impuritiestheranostic radionuclides

Autor:innen und Institutionen

  • Department of Medical Imaging Technology, Medical University of Lodz, ul. Lindleya 6, 90-131 Łódź, Poland.
  • Department of Medical Physics, Copernicus Memorial Hospital in Lodz Comprehensive Cancer Center and Traumatology, Pabianicka 62, 93-513 Łódź, Poland.
  • Institute of Applied Radiation Chemistry, Faculty of Chemistry, Lodz University of Technology, Wróblewskiego 15, 90-924 Łódź, Poland.
  • Department of Nuclear Medicine, The Regional Specialist Hospital in Olsztyn, Żołnierska 18, 10-561 Olsztyn, Poland.

ORCID-Profile: Teresa Jakubowska, Magdalena Długosz-Lisiecka, Jarosław Jankowski, Michał Biegała

Zitieren

APA

Jakubowska, T., Długosz-Lisiecka, M., Jankowski, J., & Biegała, M. (2026). Radionuclidic Impurity Pathways in Cyclotron Production: Insights from 18F and Emerging Theranostic Radionuclides. Molecules, 31(21), 3987. https://doi.org/10.3390/molecules31213987

Vancouver

Jakubowska T, Długosz-Lisiecka M, Jankowski J, Biegała M. Radionuclidic Impurity Pathways in Cyclotron Production: Insights from 18F and Emerging Theranostic Radionuclides. Molecules. 2026;31(21):3987. doi:10.3390/molecules31213987

BibTeX
@article{Jakubowska2026,
  author = {Jakubowska, Teresa and Długosz-Lisiecka, Magdalena and Jankowski, Jarosław and Biegała, Michał},
  title = {Radionuclidic Impurity Pathways in Cyclotron Production: Insights from 18F and Emerging Theranostic Radionuclides},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {21},
  pages = {3987},
  doi = {10.3390/molecules31213987}
}
Kostenlos starten →